Potential anti-neuroinflammatory compounds from Australian plants – A review. (January 2021)
- Record Type:
- Journal Article
- Title:
- Potential anti-neuroinflammatory compounds from Australian plants – A review. (January 2021)
- Main Title:
- Potential anti-neuroinflammatory compounds from Australian plants – A review
- Authors:
- Singh, Ahilya
Raju, Ritesh
Münch, Gerald - Abstract:
- Abstract: Neuroinflammation is a complex response to brain injury involving the activation of glia, release of inflammatory mediators, such as cytokines and chemokines, and generation of reactive oxygen and nitrogen species. Even though it is considered an event secondary to neuronal death or dysfunction, neuro-inflammation comprises a majority of the non-neuronal contributors to the cause and progression of neurodegenerative diseases like Alzheimer's Disease (AD), Parkinson's Disease (PD), Multiple Sclerosis (MS), Chronic Traumatic Encephalopathy (CTE) and others. As a result of the lack of effectiveness of current treatments for neurodegenerative diseases, neuroinflammation has become a legitimate therapeutic target for drug discovery, leading to the study of various in vivo and in vitro models of neuroinflammation. Several molecules sourced from plants have displayed anti-inflammatory properties in the study of neurodegenerative diseases. A group of these anti-inflammatory compounds has been classified as cytokine-suppressive anti-inflammatory drugs (CSAIDs), which target the pro-inflammatory AP1 and nuclear factor-κB signaling pathways and inhibit the expression of many pro-inflammatory cytokines, such as interleukin IL-1, IL-6, TNF-α, or nitric oxide. Australian plants, thriving amid the driest inhabited continent of the world, are an untapped source of chemical diversity in the form of secondary metabolites. These compounds are produced in response to biotic andAbstract: Neuroinflammation is a complex response to brain injury involving the activation of glia, release of inflammatory mediators, such as cytokines and chemokines, and generation of reactive oxygen and nitrogen species. Even though it is considered an event secondary to neuronal death or dysfunction, neuro-inflammation comprises a majority of the non-neuronal contributors to the cause and progression of neurodegenerative diseases like Alzheimer's Disease (AD), Parkinson's Disease (PD), Multiple Sclerosis (MS), Chronic Traumatic Encephalopathy (CTE) and others. As a result of the lack of effectiveness of current treatments for neurodegenerative diseases, neuroinflammation has become a legitimate therapeutic target for drug discovery, leading to the study of various in vivo and in vitro models of neuroinflammation. Several molecules sourced from plants have displayed anti-inflammatory properties in the study of neurodegenerative diseases. A group of these anti-inflammatory compounds has been classified as cytokine-suppressive anti-inflammatory drugs (CSAIDs), which target the pro-inflammatory AP1 and nuclear factor-κB signaling pathways and inhibit the expression of many pro-inflammatory cytokines, such as interleukin IL-1, IL-6, TNF-α, or nitric oxide. Australian plants, thriving amid the driest inhabited continent of the world, are an untapped source of chemical diversity in the form of secondary metabolites. These compounds are produced in response to biotic and abiotic stresses that the plants are exposed to in the highly biodiverse environment. This review is an attempt to highlight anti-inflammatory compounds isolated from Australian plants. Highlights: Neuroinflammation is a contributor to neurodegeneration. Anti-inflammatory phytochemicals action through their interaction modulation of the cytokine system. Australian plants - an underexploited source of molecules with therapeutic potential. Anti-inflammatory compounds from Australian plants. … (more)
- Is Part Of:
- Neurochemistry international. Volume 142(2021)
- Journal:
- Neurochemistry international
- Issue:
- Volume 142(2021)
- Issue Display:
- Volume 142, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 142
- Issue:
- 2021
- Issue Sort Value:
- 2021-0142-2021-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-01
- Subjects:
- Neuro-inflammation -- Anti-inflammatory compounds -- Cytokines
Neurochemistry -- Periodicals
Neurochemistry -- Periodicals
Neurochimie -- Périodiques
Neurochemistry
Periodicals
612.804205 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01970186 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.neuint.2020.104897 ↗
- Languages:
- English
- ISSNs:
- 0197-0186
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.317000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23458.xml